Lamotrigine/Sertraline Hydrochloride

拉莫三嗪/盐酸舍曲林

Report date: 2022/02/14 16:04:11

Base Information

Drug NameLamotrigine/Sertraline Hydrochloride

Drug Alias Name盐酸舍曲林/拉莫三嗪Lamotrigine and Sertraline Hydrochloride盐酸舍曲林拉莫三嗪Sertraline Hydrochloride+LamotrigineSertraline Hydrochloride and Lamotrigine +[16]

ClassificationSmall molecules

Mechanisms of ActionSerotonin transporter inhibitors

TargetsSodium channel alpha subunitSerotonin transporter

Therapy Area/IndicationsBack Pain

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Sertraline Hydrochloride Lamotrigine

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesMeditop Pharmaceutical

China Registration ClassN/A

Develop Information

Active CompaniesMeditop Pharmaceutical

Inactive CompaniesN/A

Active IndicationsBack Pain

Inactive IndicationsN/A

Other Information

ATC CodeN/A